Assembly Biosciences, Inc. Cash Equivalents, at Carrying Value
Assembly Biosciences, Inc. (ASMB) had Cash Equivalents, at Carrying Value of $27.84 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2024-11-07
- 2024-09-30: Cash Equivalents, at Carrying Value $27.84M.
- 2024-06-30: Cash Equivalents, at Carrying Value $18.60M.
- 2024-03-31: Cash Equivalents, at Carrying Value $18.11M.
- 2023-12-31: Cash Equivalents, at Carrying Value $18.98M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2024-09-30 | $27.84M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $18.60M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $18.11M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $18.98M 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |